Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Inorg Chem. 2010 Mar 1;49(5):2383–2391. doi: 10.1021/ic9022618

Synthesis and Reactivity of Oxo-Peroxo-Vanadium(V) Bipyridine Compounds

Christopher R Waidmann , Antonio G DiPasquale , James M Mayer ‡,
PMCID: PMC2886587  NIHMSID: NIHMS174728  PMID: 20108930

Abstract

The vanadium(IV) compound [VIVO(OH)(tBu2bpy)2]BF4 (VIVO(OH)) (tBu2bpy = 4,4′-di-tert-butylbipyridine) is slowly oxidized by O2 in ethereal solvents to give the oxo-peroxo compound [VVO(O2)(tBu2bpy)2]BF4 (VVO(O2)) in excellent yield. This and related compounds were fully characterized by NMR, IR, and optical spectroscopies, mass spectrometry, elemental analyses, and an X-ray crystal structure of the 4,4′-dimethylbipyridine analog, [VVO(O2)(Me2bpy)2]BF4. Monitoring the reaction of VIVO(OH) with O2 in THF/acetonitrile mixtures by 1H NMR and optical spectroscopies surprisingly shows that the initial product is the cis-dioxo compound [VV(O)2(tBu2bpy)2]BF4 (VVO2), which then converts to VVO(O2). Reaction of VIVO(OH) with 18O2 gives ca. 60% triply 18O labeled VVO(O2). The mechanism of formation of VVO(O2) is complex and may occur via initial reduction of O2 at vanadium(IV) to give a superoxo-vanadium(V) intermediate, autoxidation of the THF solvent, or both. That VVO2 is generated first appears to be due to the ability of VIVO(OH) to act as a hydrogen atom donor. For instance, VIVO(OH) reacts with VVO(O2) give VVO2. VVO(O2) is also slowly reduced to VIVO(OH) by the organic hydrogen atom donors hydroquinone and TEMPOH (2,2,6,6-tetramethylpiperidin-1-ol) as well as by triphenylphosphine. Notably, the peroxo complex VVO(O2) is much less reactive with these substrates than the analogous dioxo compound VVO2.

Introduction

Oxo-peroxo-vanadium(V) compounds are of interest because of their presence in the haloperoxidase enzymes found in fungi and marine algae,1 and their involvement in stoichiometric and catalytic oxidations of organic substrates.2,3 These complexes are typically prepared by reacting vanadium(IV) or vanadium(V) complexes with hydrogen peroxide or alkylperoxides.4 For catalytic applications, it is desirable to use O2 as the oxidant, and there have been a few reports of the formation of oxo-peroxo-vanadium(V) products by reaction of O2 with vanadium(IV) compounds.58 These reactions are complicated by the mismatch in redox stoichiometry: oxidation of VIV to VV is a one-electron change while reduction of dioxygen to peroxide is a two-electron process.

A particularly detailed study of a reaction of a vanadium(IV) complex with O2, by Kelm and Krüger, showed using 18O2-labelling that both peroxo oxygens in the oxo-peroxo-vanadium(V)-(py2(NMe)2) product originated from dioxygen. A VV-superoxo intermediate was also observed by EPR.6 It was proposed that this species abstracts a hydrogen atom from the THF solvent followed by deprotonation of the resulting VV-hydroperoxo species to give the final VV–peroxo product. Similar mechanisms have been proposed by Kosugi et al. for autoxidation of their tris(3,5-diisopropylpyrazolyl)borate vanadyl complex,5 and by Egdal et al. for their divanadium-phenoxyl-amine-pyridyl complexes.8 Kotchevar et al. have also proposed reduction of O2 by a vanadium(IV) (bis-cyclopentadienyl)(acetylacetonate) complex to give a vanadium(V) superoxo intermediate, which initiates peroxidation of lipids in liposomal membranes.9 In contrast, Tajika et al. attribute formation of a VVO(O2) product with a tris(2-pyridylmethyl)amine (TPA) ligand simply to peroxide formed in the solvent.7 Autoxidation of solvent10 to form catalytically active peroxo-vanadium species has also been suggested in the catalytic epoxidation of olefins,11 and alkane oxidation.12

Here we report the oxidations of vanadium(IV)-oxo-hydroxo-bipyridine compounds by O2 in THF to give oxo-peroxo-vanadium(V) products of the formula [VVO(O2)(4,4'-R2bpy)2]BF4 (R = tBu, Me, H). Bipyridine is a classic ligand for vanadium(IV) and vanadium(V) but the prior literature in this area has some inconsistencies, as described below. We came across these issues as part of our studies of hydrogen atom transfer reactions interconverting dioxo-vanadium(VI) and oxo-hydroxo-vanadium(IV) complexes.13 This report discusses the nature of the O2 reactions and their mechanisms, and describes reactions of the peroxo complex [VVO(O2)(4,4'-tBu2bpy)2]BF4 with triphenylphosphine and hydrogen atom donors. This system is unusual because the vanadium(IV) compound itself can act as a hydrogen atom donor and because the peroxovanadium(V) complex is remarkably stable.

Results

A. Synthesis and characterization of [VVO(O2)(4,4′-tBu2bpy)2]BF4, [VVO(O2)]

In an attempt to synthesize the dioxo-vanadium(V) compound [VV(O)2(tBu2bpy)2]BF4 [VVO2],13 the known vanadium(IV) hydroxo complex [VIVO(OH)(tBu2bpy)2]BF4 [VIVO(OH)]14 was stirred in THF while exposed to air. This followed a very similar procedure described by Brand et al. for the aerobic oxidation of the related vanadyl-chloride complex with unsubstituted bipyridine ligands, [VIVO(Cl)(bpy)2]ClO4.15 In this study we have mostly used the 4,4'-tBu2bpy ligand because it gives complexes with higher solubility in organic solvents, and because the vanadium(IV) derivative VIVO(OH) has an easily observed, characteristic 1H NMR spectrum with four separate tBu resonances.13 Over three days at ambient temperatures under air, a yellow suspension of the partially soluble VIVO(OH) in THF transforms into a red suspension, and addition of pentane yields a pale red solid in 97% yield. As described below, NMR, UV-Vis, IR and ESI-MS methods indicate this product is not the anticipated dioxo-vanadium(V) complex, but is instead an oxo-peroxo-vanadium(V) species, [VVO(O2)(tBu2bpy)2]BF4 [VVO(O2)] (eq 1). The peroxo complex is formed in high yield using either one atmosphere of air or one atmosphere of dry O2, but no reaction is observed under an atmosphere of N2. The reaction proceeds well in dry THF distilled from Na/Ph2CO, or in unpurified (wet) THF from a bottle on the benchtop, which contains 250 ppm of the stabilizer BHT (butylated hydroxytoluene, 2,6-tBu2-4-Me-C6H2OH). Et2O or CH3CN/THF mixtures can also be used as the solvent, but no reaction is observed when VIVO(OH) is exposed to an atmosphere of O2 in CD3CN or CD2Cl2 for three weeks. Thus VIVO(OH) has been observed to convert to VIVO(O2) only when both O2 and an ethereal solvent are present (although perhaps materials with weak C–H bonds other than ethers could also be effective).

graphic file with name nihms174728f7.jpg (1)

1H NMR spectra of VVO(O2) show that the compound is diamagnetic. The presence of 4 tBu and 12 bpy peaks indicates a C1 symmetric complex containing two inequivalent 4,4'-tBu2bpy ligands (Figure 1). Assignments of the 1H NMR spectrum were enabled by a combination of 1H 2D COSY and 2D NOESY NMR spectra. The UV-Vis spectrum of VVO(O2) in CH3CN shows a peak at 475 nm with an ε of 370 M−1 cm−1 (Figure 2), typical for a peroxo-to-vanadium charge-transfer transition.16 More intense peaks are also observed below 350 nm, presumably due to bipyridine π → π* absorptions since similar bands appear in spectra of VIVO(OH).

Figure 1.

Figure 1

1H NMR of VVO(O2) in CD3CN. The inset shows the tBu region, and * indicates the residual CD2HCN solvent peak.

Figure 2.

Figure 2

UV-Vis spectrum of VVO(O2) in acetonitrile.

ESI-MS analysis of an acetonitrile solution of VO(O2) from O2 shows a base peak at 635.5 m/z, the predicted mass for the [VVO(O2)(tBu2bpy)2]+ cation (Figure 3a). Isolation of the 635.5 peak followed by collision induced fragmentation yields one intense peak at 367.1 Dalton, corresponding to the loss of one tBu2bpy ligand to give a [VO(O2)tBu2bpy]+ fragment. FAB/MS using a nitrobenzyl alcohol matrix shows analogous results. The peak with an m/z of 619.6 in Figure 3a corresponds to a VVO2 impurity in this sample.

Figure 3.

Figure 3

ESI-MS spectra of reaction mixtures of (a) VIVO(OH) with 16O2 in THF and (b) VIVO(OH) with 18O2 in THF.

A suspension of VIVO(OH) in THF was stirred under ca. 1 atm of 18O2 (98.4 % enriched), to probe how many O atoms from O2 are incorporated in the product. ESI-MS spectra of the resulting 18O-labeled product have their most intense peak at m/z = 641.4. This is 6 Dalton larger than the most intense peak observed for V16O(16O2), indicating incorporation of three 18O atoms. Isolation and fragmentation of the 641 m/z peak yields a peak at 372.8 m/z, consistent with [V18O(18O2)tBu2bpy]+ and further supporting the presence of three 18O atoms. There is a less intense peak at 639.6 m/z, corresponding to doubly 18O labeled VVO(O2), but no peaks are observed at m/z = 635 or 637. Thus all the VVO(O2) generated is at least doubly 18O labeled, and ~60 % is triply-labeled based on the peak heights. Residual VVO2 and VIVO(OH) present in the reaction mixture give rise to peaks at 619.7, 621.6 and 622.5 m/z, indicating the presence of un-labeled and singly- and doubly-18O labeled materials.

VVO(O2) was also characterized by IR spectroscopy. Oxo-peroxo-vanadium complexes are known to have strong, distinct V=O and O–O IR stretches,3 and assignments of these stretches for VVO(O2) were confirmed by 18O labeling studies. The isotopic shifts are most clear in spectra obtained from dichloromethane solutions, as shown in Figure 4 below. The 16O compound shows a ν(V=16O) stretch at 963 cm−1 and a ν(16O–16O) stretch at 927 cm−1, typical values for oxo-peroxo-vanadium compounds.3,17 In the complex prepared from 18O2, which is predominantly triply 18O enriched, new peaks for ν(V=18O) and ν(18O–18O) appear at 919 and 874 cm−1, respectively. These isotopic shifts agree well with those predicted from a simple diatomic oscillator model, 917 and 874 cm−1. The formation of triply-labeled VVO(O2) was unexpected, but exchange of 18O labels between peroxide, water, and terminal oxo groups has been previously reported for oxo-peroxo-vanadium compounds.6,18

Figure 4.

Figure 4

IR spectra of solutions of VVO(O2) (solid green line) and V18O(18O2) (dashed blue line)in dichloromethane.

The analogs of VIVO(OH) with 4,4′-dimethyl-bipyridine and bipyridine ligands [VIVO(OH)(Me2bpy)2]BF4 and [VIVO(OH)(bpy)2]BF4 show very similar chemistry.13 These complexes are insoluble in pure THF so their reactions with O2 were performed in 1:1 CH3CN/THF mixtures. Over 24 hours under air, these solutions changed from yellow to orange, and [VVO(O2)(Me2bpy)2]BF4 and [VVO(O2)(bpy)2]BF4 were obtained in moderate yields after removal of solvent and washing with n-pentane. The NMR and UV-Vis spectra of the latter complex match those of the reported perchlorate salt, [VVO(O2)(bpy)2]ClO4, which was prepared following the more typical method of addition of H2O2 to an acidic mixture of V2O5 and ligand.19 For both [VVO(O2)(Me2bpy)2]BF4 and [VVO(O2)(bpy)2]BF4, 1H NMR spectra in CD3CN or CD2Cl2 indicate diamagnetic, C1-symmetric cations with two bipyridine ligands, similar to VVO(O2). ESI-MS and FAB-MS shows peaks consistent with [VVO(O2)(Me2bpy)2]+ and [VVO(O2)(bpy)2]+, and the IR spectra of these compounds are similar to the spectrum of VVO(O2) as well. [VVO(O2)(Me2bpy)2]BF4, for instance, shows a ν (V=O) stretch at 946 cm−1 and a ν(O–O) stretch at 923 cm−1.

X-ray quality crystals of [VVO(O2)(Me2bpy)2]BF4 were obtained by slow diffusion of Et2O into a concentrated CH3CN solution of [VVO(O2)(Me2bpy)2]BF4 in an NMR tube. The resulting structure suffers from whole molecule disorder, whereby a non-crystallographic 2-fold axis through the vanadium center rotates the oxo group into the peroxo group.20a Because of this disorder, all non-hydrogen atoms, except for V1, were refined isotropically, but no restraints were used. The BF4 anion is also rotationally disordered and was treated using the SQUEEZE routine.20b Half of the disordered cation is shown in Figure 5. Crystallographic information is given in Table 1 and selected bond lengths and angles for half of the disordered cation (which are within error of the values for the other half) are given in Table 2.

Figure 5.

Figure 5

ORTEP of the cation in [VVO(O2)(Me2bpy)2]BF4, with hydrogen atoms omitted for clarity.

Table 1.

X-ray Crystallographic Data for [VVO(O2)(Me2bpy)2]BF4.

Empirical Formula C24H24BF4N4O3V
FW 554.22
crystal system Monoclinic
Space group P2(1)/c
a (Å) 14.190(5)
b (Å) 16.245(6)
c (Å) 10.876(4)
α (°) 90
β (°) 98.568(4)
γ (°) 90
Volume (Å3) 2479.1(16)
Z 4
density (g/cm3, calcd) 1.485
μ (mm−1) 0.465
λ (Å) 0.71073
Crystal size (mm) 0.15 × 0.12 × 0.10
Temperature (K) 130(2)
θ range (°) 2.51–25.57
Index ranges −17 ≤ h ≤ 17
−19 ≤ k ≤ 16
−12 ≤ l ≤ 13
reflections collected 22202
Data / restraints / parameters 4548 / 0 / 261
Rint 0.0429
R1,wR2(I > 2σI) 0.0771, 0.2357
Goodness of fit 1.061

Table 2.

Selected bond lengths and angles for [VVO(O2)(Me2bpy)2]BF4.

Bond Length (Å) Angle (°)
V1-O1 1.869(7) O3-V1-O1 104.4(3)
V1-O2 1.877(7) O3-V1-O2 105.0(3)
V1-O3 1.556(7) O1-V1-O2 44.0(3)
O1-O2 1.402(10) N1-V1-N2 67.2(4)
V1-N1 2.198(12) N3-V1-N4 73.6(4)
V1-N2 2.334(11)
V1-N3 2.263(9)
V1-N4 2.205(10)

The x-ray structure of [VVO(O2)(Me2bpy)2]BF4 is consistent with all of the spectroscopic results discussed above and is similar to reported oxoperoxo-vanadium(V) structures.3 The O–O bond length of 1.402(10) Å is ~0.02–0.07 Å shorter than in most other oxoperoxo-vanadium(V) structures,3 however. This shorter than expected bond length may be due to the disorder between the oxo and peroxo moieties in the structure. Notably, the O–O bond length observed here is more reasonable than the previously reported, very short distances of 1.24 and 1.3 Å for [VVO(O2)(bpy)2]ClO4 and [VVO(O2)(phen)2]ClO4 (phen = 1,10 phenanthroline), respectively.19 The unusually short O–O distances in the previously reported structures are likely due to unrecognized disorder between the oxo and peroxo moieties, similar to what is observed here in [VVO(O2)(Me2bpy)2]BF4. Additionally, the V=O bond length of 1.556(7) Å in [VVO(O2)(Me2bpy)2]BF4 is ~ 0.04–0.06 Å shorter than is typical in oxoperoxo-vanadium(V) structures, which may also reflect the disorder. The strong trans effect of the oxo and peroxo groups causes a significant lengthening of the V-N bonds trans to these groups.

B. Mechanistic experiments

To probe the mechanism of formation of VVO(O2), the reaction of VIVO(OH) with O2 in CH3CN/THF solution was monitored by optical spectroscopy (Figure 6a and 6c). The THF was distilled from Na/benzophenone ketyl, so that no organic peroxides or peroxide inhibitors were present initially. After an induction period of ca. 1 hour, the VIVO(OH)max = 400 nm) began to bleach without concomitant formation of any VVO(O2) for the next five hours, based on the absence of its characteristic optical band at 475 nm. The bleaching indicates formation of VVO2, as shown by the 1H NMR experiments below. Only after ≥ 80% of the VIVO(OH) disappeared did VVO(O2) form in observable amounts, and this peroxo product continued to form over the next 25 hours to give the final 98 % yield. 1H NMR spectra of the resulting solution showed only VVO(O2), and what appeared to be THF oxidation products. GC-MS of the organic products after reaction showed formation of the γ-butyrolactone and 2-hydroxy-THF, consistent with the peaks observed by 1H NMR. A similar reaction, with VIVO(OH) under an atmosphere of O2 in a cuvette but wrapped in aluminum foil and stored in the dark, gave a quantitative yield of VVO(O2) by optical spectroscopy when checked after 2 days. The induction period observed in these reactions varied considerably, ranging from hours to several days. The reaction of a 1:1 mixture of VIVO(OH) and VVO2 (each 3 mM) in CH3CN/THF with O2 was also monitored by optical spectroscopy. After an induction period of several days, the VIVO(OH) bleached, indicating its conversion to VVO2. All the VVO2 present was then converted to VVO(O2) in just one day. The cis-dioxo compound VVO2 therefore appears to be a kinetically competent intermediate for this reaction.

Figure 6.

Figure 6

UV-Vis spectra of reaction of (a) VIVO(OH) with O2 in THF/CH3CN, (b) VVO2 with O2 in THF/CH3CN, and (c) a comparison of absorbance at 475nm versus time.

The reaction of VIVO(OH) with O2 was also monitored by 1H NMR in THF-d8/CD3CN. By NMR, the broad, paramagnetic tBu peaks of VIVO(OH)13 disappear over two days, forming predominantly the known cis-dioxo vanadium(V) complex [VV(O)2(tBu2bpy)2]BF4,13 with small (ca. 1%) amounts of VVO(O2) (eq 2). VVO2 then slowly disappears, quantitatively forming VVO(O2). This is consistent with the optical experiments above: VIVO(OH) first bleaches to form VVO2, which is d0 and has no characteristic optical absorbance, then VVO2 is converted to VVO(O2).

graphic file with name nihms174728f8.jpg (2)

To test for possible binding of O2 to the vanadium(IV) complex VIVO(OH), optical spectra were taken of a CH3CN/THF solution of VIVO(OH) before and immediately after O2 was added. There is no perceptible difference between these spectra, indicating no significant formation of a dioxygen adduct under these conditions.

The experiments above implicate VVO2 as an important intermediate in the reaction of VIVO(OH) with O2. Therefore, its reactivity with O2 has also been examined. Remarkably, solutions of VVO2 in CH3CN/THF react with air to quantitatively form the peroxo complex VVO(O2) (eq 3). This reaction is significantly slower than the one starting from VIVO(OH), requiring a week to proceed to completion (Figures 6b and 6c). An 1H NMR spectrum of an aliquot of this solution in CD3CN after complete reaction shows only VVO(O2), THF, and THF oxidation products. VVO2 is more rapidly converted to VVO(O2) in the presence of ca. 5 equivalents of the alkylperoxide tBuOOH in CD3CN, by NMR.

graphic file with name nihms174728f9.jpg (3)

We have also found that isolated VIVO(OH) quantitatively reacts with VVO(O2) in THF/MeCN to give VVO2 over several hours (eq 4). In this comproportionation reaction, the vanadium center of VIVO(OH) is oxidized to vanadium(V) while the peroxo ligand of VVO(O2) is reduced to an oxo group. This reaction was monitored by UV-Vis spectroscopy and the final vanadium products were confirmed by 1H NMR. Interestingly, only one equivalent of VIVO(OH) is consumed in the reduction of one equivalent of VVO(O2). In the opposite direction, VIVO(OH) in CD3CN reacts with ~1 equivalent of 30% aqueous H2O2 over three hours at room temperature to give VVO(O2) in good yield (by 1H NMR, eq 5).

graphic file with name nihms174728f10.jpg (4)
graphic file with name nihms174728f11.jpg (5)

C. Reactivity of the peroxo complex [VVO(O2)(tBu2bpy)2]BF4 [VVO(O2)]

Solid VVO(O2) is very stable, lasting years on the benchtop, and solutions in CD3CN over many days show no decomposition. VVO(O2) reacts with Ph3P (1.5 equivalents) over a week in dry CD3CN in a J. Young NMR tube, with the orange solution turning yellow. By both 1H and 31P NMR spectroscopies, the PPh3 is converted to Ph3PO, with only Ph3PO visible in 31P NMR spectra after one week. In the 1H NMR spectra, broad peaks corresponding to the tBu groups of VIVO(OH) grow in as VVO(O2) is reduced. A small amount of free ligand (ca. 10%) is also generated during the reaction, indicating that some other minor vanadium products must be formed. With 4.4 equivalents of Ph3P, the reaction reaches completion in approximately 3.5 days and ca. 1.7 equivalents of Ph3P are oxidized to Ph3PO.

No VVO2 is observed in the NMR spectra of the reaction of VVO(O2) with PPh3. This is surprising as most d0 peroxo complexes are reduced by phosphines to give the corresponding d0 oxo compounds.21 In this case, however, separate control experiments show that VVO2 reacts with Ph3P faster than the peroxo complex, with the reactions reaching completion within 4 hours. This reaction gives 0.5 equivalents of Ph3PO, approximately 0.5 equivalents of VIVO(OH), free ligand and other unknown products with broad peaks in the tBu region, by 1H NMR. Peroxo-vanadium(V) complexes are also known to transfer an oxygen atom to olefins to give epoxides,2 but no reaction was observed between VVO(O2) and trans-stilbene in acetonitrile over one week at 25 °C.

VVO(O2) also reacts with hydrogen atom donors. The presence of 6 equivalents of hydroquinone reduces VVO(O2) to VIVO(OH) in 90% yield (some free ligand is generated) in dry CD3CN over 5 days, as monitored by 1H NMR. The reaction reaches completion overnight at 50 °C with 10 equivalents of hydroquinone. 1.5 equivalents of hydroquinone are consumed per vanadium, and an equal amount of benzoquinone grows in over the course of the reaction, as does H2O. Equation 8 shows the balanced reaction, with 3 reducing equivalents of hydroquinone consumed to reduce the peroxo ligand by 2e and the vanadium center by 1e.

graphic file with name nihms174728f12.jpg (8)

VVO(O2) is also reduced by 2 equivalents of the hydroxylamine 2,2,6,6-tetramethyl-N-hydroxypiperidine (TEMPOH). Over 24 hours, all of the TEMPOH is consumed while approximately 60% of VVO(O2) is reduced to VIVO(OH). Three equivalents of TEMPOH would be required to fully reduce VVO(O2) to VIVO(OH), but substoichiometric amounts of TEMPOH were used to avoid the competitive reaction of TEMPOH with VIVO(OH).13

Discussion

A. Synthesis of the peroxo complex VVO(O2)

The formation of a vanadium(V) peroxo complex from a vanadium(IV) species and O2 is a surprising reaction because of the mismatch in redox stoichiometry. The vanadium is oxidized by one electron and the dioxygen is reduced by 2e. It is even more odd that VVO(O2) is formed quantitatively from the vanadium(V) dioxo complex VVO2 and O2 in CH3CN/THF, without any redox change at the vanadium. In these reactions, the ether solvent provides some or all of the reducing equivalents needed to form the peroxo ligand, as indicated by the formation of γ-butyrolactone and 2-hydroxy-THF from THF. In the absence of a reducing solvent, in CH2Cl2 or MeCN, VIVO(OH) is unreactive with O2. The formation of oxidized THF products upon reaction of a vanadium(IV) complex with O2 has previously been reported,6 as have stoichiometric and catalytic aerobic oxidations of THF mediated by a variety of transition metal and main group complexes.22

We originally investigated the reaction of VIVO(OH) with O2 based on the report of Brand et al. that [VIV(O)Cl(bpy)2]Cl in THF is oxidized by O2 to [VV(O)2(bpy)2]Cl. Their product was characterized by elemental analysis, IR and optical spectroscopies, and an X-ray crystal structure.15 Brand’s report contrasts with our observations that the related hydroxy complexes [VIV(O)OH(R2bpy)2]BF4 react with O2 to yield oxo-peroxo complexes, and form dioxo species only as transient intermediates. In retrospect, it appears that the product prepared by Brand et al. most likely contained a substantial amount of the peroxo complex. Most notably, the optical spectrum of Brand et al.’s “[VV(O)2(bpy)2]Cl” is reported to have a peak at 475 nm with a molar absorptivity of 340 M−1 cm−1, a transition characteristic of oxoperoxovanadium(V) compounds.3 The [VVO(O2)(bpy)2]BF4 reported here has this band at λ = 475 nm, ε = 370 M−1 cm−1. In contrast, the authentic cis-dioxo compound, [VV(O)2(bpy)2]BF4, is yellow with no distinct peaks above 350 nm.13 Our assignments have been confirmed by 1H NMR spectra, which Brand et al. did not report. They do give an elemental analysis of the chloride hydrate, “[VV(O)2(bpy)2]Cl·H2O,” but this has a calculated elemental composition that is essentially indistinguishable from the peroxo compound [VVO(O2)(bpy)2]Cl. The dioxo cation [VV(O)2(bpy)2]+ has now been reported four times, with Brand et al.’s report being the first, the next two being hydrothermal syntheses where only single crystals were characterized.23 In light of these issues, we recommend synthesizing the simple [VV(O)2(R2bpy)2]+ salts directly from aqueous vanadate and the bipyridine ligand, as we recently reported.13

B. Comments on the mechanism of formation of the peroxo complex VVO(O2)

The mechanism of conversion of VIVO(OH) to VVO(O2) is clearly complex. As mentioned above, two types of mechanisms have been discussed for the oxidation of vanadium(IV) compounds by O2. Initial binding of O2 to a vanadium(IV) species could form a vanadium(V)-superoxide complex. Such a VV(O2•−) species has been prepared electrochemically and observed by ESR by Kelm and Krüger, although it was generated by oxidation of a VV-peroxo complex rather than from VIV + O2.6 If the chemistry described here proceeds via initial binding of O2 to VIV, this must be an unfavorable equilibrium since no spectral change is observed when O2 is added to solutions of VIVO(OH) and no reaction is observed in the absence of an ether solvent. One could imagine a pathway in which an unobserved vanadium(V)-oxo-superoxo intermediate such as “[(tBu2bpy)2VVO(O2•−)]2+” abstracts a hydrogen atom from VIVO(OH), yielding VVO2 and VVO(O2) and H+.5 The VVO(O2) would then be reduced by another equivalent of VIVO(OH) to form more VVO2. This reduction of VVO(O2) is likely to occur via formation of vanadium-hydroperoxo intermediates, which may generate small amounts of reactive organic species via homolysis of a VO-OH bond24 or oxidation of THF. However, such a pathway does not explain the induction period or lack of autoxidation of VIVO(OH) in less oxidizable solvents.

It has also been suggested that organic peroxides play a key role in the aerobic formation of vanadium peroxides from vanadium(IV) starting materials.7,11,12 The above observations and the presence of a variable induction period for the bleaching of VIVO(OH) is consistent with such a pathway, where unobserved reactive intermediates require some time to reach sufficient concentrations. The reaction does not appear to be initiated by reactive species already present in the solvent, such as an organic hydroperoxide, as it proceeds similarly in ‘benchtop’ THF and THF freshly distilled from benzophenone ketyl. It is not evident what process generates the reactive intermediates, as VIVO(OH) is quite stable in THF and THF/CH3CN mixtures in the absence of O2. The observation of oxidized THF products is consistent with both this mechanism and the one in the previous paragraph.

The initially observed product of air oxidation of VIVO(OH) is VVO2 (eq 2, Figure 6a), but this is not mechanistically very informative. VVO2 could form directly, but it is also possible that the initial product is VVO(O2) which rapidly comproportionates with VIVO(OH) to give VVO2 (eq 4). This is a unique feature of this system, probably related to the ability of VIVO(OH) to act as a hydrogen atom donor. In previous work,13 VIVO(OH) was shown to have a weak O-H bond, with a bond dissociation free energy (BDFE)25 of only 70.6 kcal mol−1. For instance, VIVO(OH) reversibly transfers a hydrogen atom to the stable phenoxyl radical 2,6-di-tert-butyl-4-methoxy-phenyl (ArO) forming an equilibrium with VVO2 and the corresponding phenol. Thus the reduction of VVO(O2) by VIVO(OH) is very similar to the reductions of VVO(O2) by the organic H-atom transfer agents TEMPOH and hydroquinone.

The conversion of VVO2 to VVO(O2) with O2, with its unusual stoichiometry of 2e reduction of O2 without change in the vanadium oxidation state (eq 3, Figure 5b), must also have a complex mechanism. Again the data are consistent with the reaction being mediated by small concentrations of reactive oxygen species. In particular, VVO2 is consumed faster when it is formed as an intermediate in reactions of VIVO(OH), in which reactive species have presumably built up to significant concentrations. The observation that t BuOOH converts VVO2 to VVO(O2) implies that this transformation could be accomplished by other hydroperoxides, such as the autoxidation intermediate 2-hydroperoxy-THF.26 Additionally, VVO2 may be capable of abstracting H from the THF solvent to start an autoxidation radical chain as VVO2 is known to stoichiometrically abstract H from xanthene and dihydroanthracene under anaerobic conditions. These species, however, have very weak C–H bonds (bond dissociation enthalpies ~ 80 kcal mol−1), close to that of VIVO(OH) and substantially weaker than the α-C-H bonds of THF (BDE 92 kcal mol−1).27 Consistent with these bond strengths, no reaction occurs between VVO2 and THF over days in the absence of O2, as monitored by NMR or UV-Vis spectroscopies. Still, an undetectable amount of reaction could be sufficient to generate the small amount of reactive species needed to initiate the autoxidation reaction.

Ultimately, all of the processes described above could be occurring during the oxidation of VIVO(OH) by O2. In this light, it is remarkable that VVO(O2) is generated in essentially quantitative yield, which highlights the stability of this peroxovanadium complex.

C. Reactivity with Organic Substrates

Peroxo-vanadium compounds, like related d0 peroxo compounds of molybdenum, tungsten, and titanium, are commonly used as oxygen atom transfer reagents.2,21,28 Still, reactions of phosphines with vanadium-oxo-peroxo complexes have only rarely been described. We have found two reports of V(O)(O2)Ln species transferring one oxygen atom to Ph3P to give Ph3PO and a cis-dioxo-vanadium product.5,29 In the vanadium-catalyzed oxidation of triarylphosphines by H2O2 in acidic MeCN/H2O, however, the anionic diperoxo compound VVO(O2)2 is the reactive species while the monoperoxo and cis-dioxo species do not contribute to the observed reaction rate.30

In the system studied here, VVO(O2) oxidizes Ph3P to Ph3PO over a few days at ambient temperatures, but the product is VIVO(OH) not VVO2. This is because PPh3 reacts more quickly with VVO2 than with the peroxo complex, as shown by independent experiments. Mostly likely, VVO2 is deoxygenated by Ph3P to give a transient oxovanadium(III) species which comproportionates with a second VVO2 to give two molecules of vanadium(IV).31 This pathway, summarized by eqs 6 and 7, accounts for the stoichiometry of 1.5 equiv of Ph3PO per VVO(O2) and requires 0.5 equivalent of adventitious water to form VIVO(OH). Consistent with this suggested pathway, Zhang and Holm have reported that VVOCl4 reacts with PhP3 to give VIIICl4(CH3CN)2 and Ph3PO, and that VIII can accept an oxygen atom from iodosylbenzene or VVO2Cl2.32 It is interesting and unusual that VVO2 is more reactive with Ph3P than is VVO(O2), reaching completion in just a few hours instead of days.

graphic file with name nihms174728f13.jpg (6)
graphic file with name nihms174728f14.jpg (7)

Reynolds and Butler have reported that oxygen-atom transfer reactivity of V-, Mo- and W-peroxo compounds correlate with both the peroxo O–O stretching frequency and the λmax of the peroxide-to-metal charge transfer absorption in electronic absorption spectra.28 They note that metal monoperoxo compounds are much poorer oxygen-atom transfer reagents than metal diperoxo compounds and that V(V) peroxo complexes are generally less reactive than Mo(IV) or W(IV) peroxides. The observed O–O bond length of 1.402 Å for [VVO(O2)(Me2bpy)2]BF4 is slightly shorter than is typical for peroxo-vanadium complexes.3 Additionally, both the ν(O–O) of 927 cm−1 and the λmax of 475 nm for VVO(O2), while typical for a vanadium(V) monoperoxo complex, are relatively high for metal-peroxo complexes. Taken together, these data suggest that the O–O bond in VVO(O2) is relatively strong and not very activated towards attack of substrates.

The reactions of VVO(O2) with the hydrogen atom donors hydroquinone and TEMPOH also occur much more slowly than analogous reactions of VVO2, with rates that differ by an order of magnitude or more at similar concentrations.13 We have noted previously that the dioxo compound is an unusually slow hydrogen atom acceptor,13 so it is interesting that the oxo-peroxo complex is even less reactive. Tajika et al. have reported similar results for the reduction of tris(3-pyridyl)methylamine oxo-peroxo-vanadium and dioxo-vanadium compounds with 2,6-di-tert-butylphenol and α-terpinene.33 The first step of these reactions could be VVO(O2) abstracting a hydrogen atom from the substrate to give a hydroperoxo-vanadium(IV) intermediate, which is probably slow because it is significantly uphill (eq 8).34 A similar step has been proposed in the intramolecular oxidation of isopropanol to acetone by peroxovanadium(V).35

graphic file with name nihms174728f15.jpg (8)

Conclusions

Oxo-peroxo-vanadium(V) complexes of the formula VVO(O2)(4,4'-R2bpy)2]BF4 (R = tBu [VVO(O2)], Me, or H) have been prepared by the air oxidation of vanadium(IV)-oxo-hydroxo complexes [VVO(OH)(4,4'-R2bpy)2]BF4 (R = tBu [VIVO(OH)], Me, or H) in THF. The unusual stoichiometry, with vanadium being oxidized by 1e but O2 undergoing 2e reduction, is accounted for by the concomitant oxidation of the THF solvent. The autoxidation of VIVO(OH) appears to involve an initial induction period, followed by close to quantitative formation of the cis-dioxo-vanadium(V) species ([VVO2(4,4'-tBu2bpy)2]BF4, VVO2) before the final VVO(O2) product forms. Remarkably, VVO2 also undergoes autoxidation in THF to the peroxo complex VVO(O2), without change in the vanadium oxidation state. VVO(O2) is reduced by the weak hydrogen atom donor VIVO(OH) to give VVO2. VVO(O2) is also reduced by the organic hydrogen atom donors hydroquinone and TEMPOH, as well as the oxygen atom acceptor Ph3P, all yielding VIVO(OH). The peroxo species VVO(O2) is significantly less reactive with these organic reductants than the corresponding dioxo species VVO2, indicating that peroxo-vanadium(V) species are not always as reactive as often assumed.

Experimental Section

Reagent grade chemicals were obtained from Aldrich, Eastman Organic or Strem and used without further purification. Reagent grade solvents were purchased from Fisher Scientific or EMD chemicals. Anhydrous acetonitrile (<10 ppm H2O) was purchased from Honeywell Burdick & Jackson, sparged with argon and plumbed from a steel keg directly into the glovebox. 18O2 (98.4 % 18O enrichment) gas was obtained from Isotec laboratories. Deuterated solvents and H218O (95% 18O-enrichment) were obtained from Cambridge Isotope Laboratories. CD2Cl2 was dried by stirring over CaH2 followed by vacuum transfer and stored in a dark bottle in a glovebox. CD3CN was dried over CaH2, vacuum transferred to P2O5 for 30 min, then CaH2 again and transferred to a clean flask and stored in a glovebox. THF and THF-d8 were stored over Na/ketyl and freshly vacuum transferred before use. TEMPOH36 was prepared following literature procedures. Hydroquinone was recrystallized from acetonitrile.

The vanadium(IV) compounds [VIVO(OH)(4,4′-R2bpy)2]BF4 were prepared following the literature procedure.13 Compounds were stored in a N2 glovebox and reactions were performed under N2 using standard glovebox and Schlenk techniques. 1H and 13C NMR spectra were recorded on Bruker Avance or DRX spectrometers (300 and 500 MHz) at ambient temperatures and are referenced to a solvent peak. Electrospray ionization mass spectra (ESI/MS) were obtained on a Bruker Esquire-LC ion trap mass spectrometer as solutions in acetonitrile, and an Agilent 5973 was used to acquire GC-MS data. IR spectra were recorded as KBr pellets or CH2Cl2 solutions in a cell with NaCl windows (as noted) using either a Perkin-Elmer 1720 or a Bruker Vector 33 FT-IR spectrometer. UV-vis spectra were recorded using a Hewlett-Packard 8453 spectrometer.

[VVO(O2)(4,4′-tBu2bpy)2]BF4 [VVO(O2)]

VIVO(OH) (200 mg, 0.28 mmol) was mixed with THF (200 mL) in a round bottom flask that was sealed with a septum and vented to air with a needle. The stirred mixture changed from yellow to red in color over the course of 3 days. The solvent was then removed via rotovap, and the solids re-dissolved in CH2Cl2. Dropwise addition of n-pentane gave a red precipitate, which was isolated by vacuum filtration and dried in vacuo to give 0.331 g (98 % yield) of red-orange product. Anal. Calcd for [VVO(O2)]•H2O, C36H50BF4N4O4V: C, 58.39; H, 6.81; N, 7.65. Found: C, 58.45; H, 6.57; N, 7.69. 1H NMR (CD3CN): one tBu2bpy ligand; δ1.24, 1.59 (each s, 9H, tBu); 6.72, 9.64 (each d, 6 Hz, 1H, 6,6′-H); 7.10, 8.17 (each dd, 6, 2 Hz, 1H, 5,5′-H); 8.21, 8.59 (each d, 1 Hz, 1H, 3,3′-H); 2nd tBu2bpy ligand: 1.34 , 1.60 (each s, 9H, tBu); 7.59, 10.36 (each d, 6 Hz, 1H, 6,6′-H); 8.12, 7.43 (each dd, 6, 2 Hz, 1H, 5,5′-H); 8.43, 8.59 (each d, 2 Hz, 1H, 3,3′-H). 13C{1H} NMR (CD3CN): δ30.11, 30.12, 30.35, 30.44 [C(CH3)3]; 36.24, 36.40, 36.96 (2C) [C(CH3)3]; 120.77, 122,04, 122.07, 122.85, 124.22, 125.71, 126.31, 126.62, 147.18, 148.76, 151.03, 151.22, 153.42, 153.79, 153.82, 155.33, 166.15, 167.08, 168.75 (bpy). IR(KBr pellet, in cm−1): 965 s ν(V=O), 585cm−1 m and 558 w ν(V–O), 927 s ν(O–O), 1616 vs ν(C=C, C=N), 2962 vs ν(CH3), 3121 m ν(bpy C–H). UV-Vis [λ/nm, (ε/M−1 cm−1)]: 475(370), 311(24000), 253(91000). ESI/MS (CH3CN): 635 [VVO(O2) - BF4]+, 619 [VVO(O2) - O - BF4]+.

[VV(18O)(18O2)(4,4′-tBu2bpy)2]BF4

Dry THF (10 mL, stored under N2, over sodium benzophenone) was vacuum transferred to a 25 mL round-bottom flask containing VIVO(OH) (15 mg, 0.021 mmol). This mixture was frozen with a liquid nitrogen/pentane bath (−131°) and the flask was exposed to ca. 1 atmosphere of 18O (1 L, 98.4 atom% 18O) and sealed. After stirring for 24 hours, the yellow mixture became orange. Pentane (10 mL) was vacuum transferred onto the THF mixture, and the solvents were poured off to give a red-orange solid which was dried under vacuum. IR (KBr pellet, cm−1): 920 s ν(V=18O), 569 m and 521 m ν(V–18O), 876 s ν(O–O). (CH2Cl2 solution, cm−1): 919 s ν(V=18O), 874 s ν(O–O). ESI/MS (CH3CN): 641.3 [V18O3(tBu2bpy)2]+, 639.7 [V18O2 16O(tBu2bpy)2]+, 623.3 [V18O2(tBu2bpy)2]+, 621.9 [V18O16O(tBu2bpy)2]+.

[VVO(O2)(4,4′-Me2bpy)2]BF4

A yellow solution of [VIVO(OH)(4,4′-Me2bpy)2]BF4 (100 mg, 0.185 mmol) in MeCN/THF (1:1 v/v, 200 mL) was stirred overnight while open to air, turning orange. The solvent was removed by rotovap to give a red orange solid which was washed with THF and dried in vacuo (0.060 g 60 % yield). Anal. Calcd for [VVO(O2)(4,4′-Me2bpy)2]BF4, C24H24BF4N4O3V: C, 52.01; H, 4.36; N, 10.11. Found: C, 51.86; H, 4.28; N, 9.91. 1H NMR (CD3CN): δ2.30, 2.44, 2.74, 2.75(each s, 3H, Me); 6.65, 7.51, 9.59, 10.30 (each d, 5.2–5.7 Hz, 1H, 6,6′-bpy H); 6.90, 7.23, 7.93, 7.98 (each d, 5.0–5.8 Hz, 1H, 5,5′-bpy H); 8.05, 8.30, 8.45, 8.47 (each s, 1H, 3,3′-bpy H). 13C{1H} NMR (CD3CN): δ 21.36, 21.92, 21.99 (2 C) [CH3]; 124.14, 125.42 (2 C), 126.26, 128.05, 129.38, 129.94, 130.27, 146.94, 148.49, 150.85, 150.89, 153.03, 153.48, 153.57, 154.11, 155.00, 155.23, 156.87, 157.61 (bpy). IR(KBr pellet, cm−1): 946 s ν(V=O), 923 s ν(O–O), 1619 vs ν(C=C, C=N). UV-Vis [λ/nm, (ε/M−1 cm−1)]: 472(364). ESI/MS (CH3CN): 467 [VO3(4,4′-Me2bpy)2]+, 451 [VO2(4,4′-Me2bpy)2]+.

[VVO(O2)(bpy)2]BF4

A yellow solution of [VIVO(OH)(bpy)2]BF4 (100 mg, 0.207 mmol) was dissolved in MeCN/THF (1:1 v/v, 200 mL) and stirred for 40 hours while open to air, turning grapefruit red in color. The solvent was removed by rotovap to give a red orange solid which was washed with THF and dried in vacuo (0.04 g, 40% yield). Anal. Calcd for [VVO(O2)(bpy)2]BF4•1/2H2O, C20H17BF4N4O3.5V: C, 47.37; H, 3.38; N, 11.05. Found: C, 47.66; H, 3.10; N, 11.02. 1H NMR (CD3CN): δ6.86, 7.70, 9.81, 10.53 (each d, 4.6–5.3 Hz, 1H, 2,2′-bpy H); 7.11, 7.43, 7.91 (each t, 1H, 3,3′-bpy H); 8.14 m, 8.21 m, 8.5 d, 8.64 m, 8.59 m (2H each, remaining bpy H). 13C{1H} NMR (CD3CN): δ123.69, 125.02, 125.10, 125.85, 127.65, 129.06, 129.55, 129.84, 141.59, 142.52, 143.92, 144.56, 147.66, 147.66, 149.28, 150.95, 151.71, 153.35, 153.73, 154.42, 155.38. IR(KBr pellet, cm−1): 953 s ν(V=O), 923 s ν(O–O), 1607 vs ν(C=C, C=N). UV-Vis [λ/nm, (ε/M−1 cm−1)]: 474(370).

Supplementary Material

1_si_001

Acknowledgement

We thank the U.S. National Institutes of Health (GM50422) and the University of Washington for financial support. We also thank Dr. Martin Sadilek for assistance with mass spectrometry.

Footnotes

Supporting Information Available: CIF for the structure of [VVO(O2)(Me2bpy)2]BF4.

References

  • 1.(a) Butler A. Curr. Opin. Chem. Biol. 1998;2:279–285. doi: 10.1016/s1367-5931(98)80070-7. [DOI] [PubMed] [Google Scholar]; (b) Butler AJ. Coord. Chem. Rev. 1999;187:17–35. [Google Scholar]
  • 2.(a) Hirao T. Chem. Rev. 1997;97:2707–2724. doi: 10.1021/cr960014g. [DOI] [PubMed] [Google Scholar]; (b) Butler A, Clague MJ, Meister GE. Chem. Rev. 1994;94:625–638. [Google Scholar]
  • 3.For a recent example, see: Hanson SK, Baker RT, Gordon JC, Scott BL, Andrew D, Sutton AD, Thorn DL. J. Am. Chem. Soc. 2009;131:428–429. doi: 10.1021/ja807522n.
  • 4.Funahashi T, Funada S, Inamo M, Kurita R, Tanaka M. Inorg. Chem. 1992;21:2202–2205. [Google Scholar]
  • 5.Kosugi M, Hikichi S, Akita M, Moro-oka Y. J. Chem. Soc., Dalton Trans. 1999:1369–1371. [Google Scholar]
  • 6.Kelm H, Krüger H. Angew. Chem. Int. Ed. 2001;40:2344–2347. doi: 10.1002/1521-3773(20010618)40:12<2344::AID-ANIE2344>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  • 7.Tajika Y, Tsuge K, Sasaki Y. J. Chem. Soc., Dalton Trans. 2005:1438–1447. doi: 10.1039/b414532a. [DOI] [PubMed] [Google Scholar]
  • 8.Egdal RK, Bond AD, McKenzie CJ. Dalton. Trans. 2009:3833–3839. doi: 10.1039/b901633c. [DOI] [PubMed] [Google Scholar]
  • 9.Kotchevar AT, Ghosh P, DuMez DD, Uckun FM. J. Inorg. Biochem. 2001;83:151–160. doi: 10.1016/s0162-0134(00)00187-2. [DOI] [PubMed] [Google Scholar]
  • 10.Valentine JS, Foote CS, Greenberg A, Liebman JF, editors. Active Oxygen in Chemistry. London: Blackie Academic & Professional; 1995. pp. 24–65. [Google Scholar]
  • 11.Chang CJ, Labinger JA, Gray HB. Inorg. Chem. 1997;36:5927–5930. doi: 10.1021/ic970824q. [DOI] [PubMed] [Google Scholar]
  • 12.Kobayashi H, Yamanaka I. Chem. Lett. 2007;36:114–115. [Google Scholar]
  • 13.Waidmann CR, Zhou X, Tsai EA, Kaminsky W, Hrovat DA, Borden WT, Mayer JM. J. Am. Chem. Soc. 2009;131:4729–4743. doi: 10.1021/ja808698x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Triantafillou GD, Tolis EI, Terzis A, Deligiannakis Y, Raptopoulou CP, Sigalas MP, Kabanos TA. Inorg. Chem. 2004;43:79–91. doi: 10.1021/ic034440d. [DOI] [PubMed] [Google Scholar]
  • 15.Brand SG, Edelstein N, Hawkins CJ, Shalimoff G, Snow MR, Tiekink ERT. Inorg. Chem. 1990;29:434–438. [Google Scholar]
  • 16.Sivak M, Schwendt P. Trans. Met. Chem. (London) 1989;14:273–276. [Google Scholar]
  • 17.(a) Colpas GJ, Hamstra BJ, Kampf JW, Pecoraro VL. J. Am. Chem. Soc. 1996;118:3469–3478. [Google Scholar]; (b) Mimoun H, Saussine L, Daire E, Postel M, Fischer J, Weiss R. J. Am. Chem. Soc. 1983;105:3101–3110. [Google Scholar]; (c) Schwendt P, Ahmed M, Marek J. Inorg. Chim. Acta. 2005;358:3573–3580. [Google Scholar]
  • 18.Bortolini O, Di Furia F, Modena G. J. Am. Chem. Soc. 1981;103:3924–3926. [Google Scholar]
  • 19.(a) Sergienko VS, Borzunov VK, Porai-Koshits MA, Loginov SV. Russ. J. Inorg. Chem. 1988;33:913–914. [Google Scholar]; (b) Sergienko VS, Borzunov VK, Porai-Koshits MA, Loginov SV. Russ. J. Inorg. Chem. 1992;37:534–543. [Google Scholar]
  • 20.(a) See the CIF file in the supporting information for further details. Spek AL. PLATON, A Multipurpose Crystallographic Tool. Utrecht, The Netherlands: Utrecht University; 2005.
  • 21.Holm RH. Chem. Rev. 1987;87:1401–1449. [Google Scholar]
  • 22.(a) Morales-Juarez J, Cea-Olivares R, Moya-Cabrera MM, Jancik V, Garcia-Montalvo V, Toscano RA. Inorg. Chem. 2005;44:6924–6926. doi: 10.1021/ic050724h. cf. [DOI] [PubMed] [Google Scholar]; (b) Moreira RF, Tshuva EY, Lippard SJ. Inorg. Chem. 2004;43:4427–4434. doi: 10.1021/ic049460+. [DOI] [PubMed] [Google Scholar]; (c) Zhang CX, Liang H, Kim E, Shearer J, Helton ME, Kim E, Kaderli S, Incarvito CD, Zuberbuhler AD, Rheingold AL, Karlin KD. J. Am. Chem. Soc. 2003;125:634–635. doi: 10.1021/ja028779v. [DOI] [PubMed] [Google Scholar]; (d) Straub T, Koskinen AMP. Inorg. Chem. Commun. 2002;5:1052–1055. [Google Scholar]; (e) Reetz MT, Toller K. Tetrahedron Lett. 1995;36:9461–9464. [Google Scholar]; (f) Sommovigo M, Alper H. J. Mol. Catal. 1981:151–158. [Google Scholar]; (g) MacDonnell FM, Fackler NLP, Stern C, O’Halloran TV. J. Am. Chem. Soc. 1994;116:7431–7432. [Google Scholar]; (h) Li P, Alper H. J. Mol. Catal. 1992:143–152. [Google Scholar]; (i) Hirai K, Nutton A, Maitlis PM. J. Mol. Catal. 1981;10:203–211. [Google Scholar]
  • 23.(a) Qi Y, Yang Y, Cao M, Hu C, Wang E, Hu N, Jia H. J. Mol. Struct. 2003;648:191–201. [Google Scholar]; (b) Su C, Huang G, Liu S, Wang S, Liao F. J. Chin. Chem. Soc. 1998;45:67–70. [Google Scholar]
  • 24.(a) DiPasquale AG, Hrovat DA, Mayer JM. Organometallics. 2006;25:915–924. doi: 10.1021/om050818z. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) DiPasquale AG, Kaminsky W, Mayer JM. J. Am. Chem. Soc. 2002;124:14534–14535. doi: 10.1021/ja028500a. [DOI] [PubMed] [Google Scholar]
  • 25.Mader EA, Davidson ER, Mayer JM. J. Am. Chem. Soc. 2007;129:5153–5166. doi: 10.1021/ja0686918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Robertson A. Nature (London) 1948;162:153. doi: 10.1038/162153a0. [DOI] [PubMed] [Google Scholar]
  • 27.(a) Laarhoven LJJ, Mulder P. J. Phys. Chem. B. 1997;101:73–77. [Google Scholar]; (b) Laarhoven LJJ, Mulder P, Wayner DDM. Acc. Chem. Res. 1999;32:342–349. [Google Scholar]
  • 28.Reynolds MS, Butler A. Inorg. Chem. 1996;35:2378–2383. doi: 10.1021/ic951212d. [DOI] [PubMed] [Google Scholar]
  • 29.Maurya MR, Khurana S, Zhang W, Rehder D. J. Chem. Soc., Dalton Trans. 2002:3015–3023. [Google Scholar]; (c) Kosugi M, Hikichi S, Akita M, Moro-aka Y. J. Chem. Soc., Dalton Trans. 1999:1369–1371. [Google Scholar]
  • 30.Du G, Espenson JH. Inorg. Chem. 2005;44:2465–2471. doi: 10.1021/ic048290y. [DOI] [PubMed] [Google Scholar]
  • 31.The VIII intermediate could also react with VVO(O2) to give two molecules of VV(O)2, which would then react further with PPh3. Including this step does not affect the overall stoichiometry of 1.5 PPh3 per VVO(O2).
  • 32.Zhang Y, Holm RH. Inorg. Chem. 1990;29:911–917. [Google Scholar]
  • 33.Tajika Y, Tsuge K, Sasaki Y. Chem. Lett. 2006;35:1180–1181. [Google Scholar]
  • 34.Initial electron transfer is unlikely because VVO(O2)tBu should be a poor one-electron oxidant: In reference 7, Tajika et al. report the VV/VIV E1/2 for the very similar tris(2-pyridylmethyl)amine oxoperoxovanadium(V) complex as −1.43 V vs. Cp2Fe+/0 in MeCN.
  • 35.(a) Bonchio M, Bortolini O, Carraro M, Conte V, Primon S. J. Inorg. Biochem. 2000;80:191–194. doi: 10.1016/s0162-0134(00)00031-3. [DOI] [PubMed] [Google Scholar]; (b) Bortolini O, Conte V, Di Furia F, Modena G. Nouv. J. Chim. 1985;9:147–150. [Google Scholar]
  • 36.Mader EA, Larsen AS, Mayer JM. J. Am. Chem. Soc. 2004;126:8066–8067. doi: 10.1021/ja049246k. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES